- Page 10: F. A. Davis Company1915 Arch Street
- Page 16: F O R E W O R DThe current healthca
- Page 24: C O N T R I B U T O R SJanet D. All
- Page 28: R E V I E W E R STammy L. Austin-Ke
- Page 36: C O N T E N T SForewardIntroduction
- Page 40: Contents xixKnowledge of Existing S
- Page 44: I N T R O D U C T I O NJoan M. Stan
- Page 48: Introduction xxiiiJuly 2009, 45 org
- Page 52:
Chapter 2The legacy of utopian desi
- Page 56:
Introduction xxviistandards that CN
- Page 60:
Introduction xxixother APRNs are a
- Page 64:
Introduction xxxiIn 2008 the NONPF
- Page 68:
Advanced PracticeNURSINGEMPHASIZING
- Page 72:
C H A P T E R 1The Evolutionof Adva
- Page 76:
The Evolution of Advanced Practice
- Page 80:
The Evolution of Advanced Practice
- Page 84:
The Evolution of Advanced Practice
- Page 88:
The Evolution of Advanced Practice
- Page 92:
The Evolution of Advanced Practice
- Page 96:
The Evolution of Advanced Practice
- Page 100:
The Evolution of Advanced Practice
- Page 106:
20 Chapter 1emerging emphasis on he
- Page 110:
22 Chapter 1The fourth myth, accord
- Page 114:
24 Chapter 1Similarities and Differ
- Page 118:
26 Chapter 1Table 1-1 Comparison of
- Page 122:
28 Chapter 14. After reading this c
- Page 126:
30 Chapter 128. Tobin, M. (2003). P
- Page 130:
Julie Stanik-Hutt is an Associate P
- Page 134:
34 Chapter 2What advanced practice
- Page 138:
36 Chapter 2By race and ethnicity,
- Page 142:
38 Chapter 2public-sector resources
- Page 146:
40 Chapter 2Managed CareStill laggi
- Page 150:
42 Chapter 2procedures. 39 The spec
- Page 154:
44 Chapter 2services at a lower cos
- Page 158:
46 Chapter 2large population of pat
- Page 162:
48 Chapter 2process, including the
- Page 166:
50 Chapter 2Nebraska, Idaho, Minnes
- Page 170:
52 Chapter 2Although APRNs should e
- Page 174:
54 Chapter 2regulatory boards and r
- Page 178:
56 Chapter 2SummaryFor more than 10
- Page 182:
58 Chapter 219. Agency for Healthca
- Page 186:
60 Chapter 260. American Associatio
- Page 190:
Mary Knudtson is the executive dire
- Page 194:
64 Chapter 3In Dr. Jan Tower’s re
- Page 198:
66 Chapter 3increased at a yearly r
- Page 202:
68 Chapter 3Other Public12% Other P
- Page 206:
70 Chapter 3Medicare (Parts A and B
- Page 210:
72 Chapter 3PRIVATE OUTLAYS■ Rati
- Page 214:
74 Chapter 3Blue Shield. Currently,
- Page 218:
76 Chapter 3health insurance, and t
- Page 222:
78 Chapter 3to hospitals the cost-p
- Page 226:
80 Chapter 3efficiency measures suc
- Page 230:
82 Chapter 3BOX 3-1 | The Character
- Page 234:
84 Chapter 3to minimize inappropria
- Page 238:
86 Chapter 315. Moon, M. (2001). He
- Page 242:
Michelle Walsh is a pediatric nurse
- Page 246:
90 Chapter 4This chapter provides a
- Page 250:
92 Chapter 4Fiedler continued to pr
- Page 254:
94 Chapter 4depending on their appr
- Page 258:
96 Chapter 44. These systems seek p
- Page 262:
98 Chapter 4attitudes, and/or behav
- Page 266:
100 Chapter 4Table 4-2 The Research
- Page 270:
102 Chapter 4The most common critic
- Page 274:
104 Chapter 4In addition to the sta
- Page 278:
106 Chapter 4and physiological arou
- Page 282:
108 Chapter 4of Benner’s work for
- Page 286:
110 Chapter 4The collaborative prac
- Page 290:
112 Chapter 43. Fleishman, EA (1973
- Page 294:
Margaret T. Bowers is assistant cli
- Page 298:
116 Chapter 5CHAPTER OUTLINESUMMARY
- Page 302:
118 Chapter 5More recently, the IOM
- Page 306:
120 Chapter 5COMPARISON IN STANDARD
- Page 310:
122 Chapter 5Table 5-2 Approaches t
- Page 314:
124 Chapter 5This need for primary
- Page 318:
126 Chapter 5contribute to the long
- Page 322:
128 Chapter 5and in 1995 the Americ
- Page 326:
130 Chapter 5team covered an averag
- Page 330:
132 Chapter 5Nurse practitioners ca
- Page 334:
134 Chapter 5populations (prisoners
- Page 338:
136 Chapter 5model, the decision to
- Page 342:
138 Chapter 5Policies related to he
- Page 346:
140 Chapter 519. Showstack, J, Luri
- Page 350:
142 Chapter 561. Daly, B. (1997). A
- Page 354:
144 Chapter 5108. Richmond, T, Thom
- Page 360:
C H A P T E R 6Formulationand Appro
- Page 364:
Formulation and Approval of Credent
- Page 368:
Formulation and Approval of Credent
- Page 372:
Formulation and Approval of Credent
- Page 376:
Formulation and Approval of Credent
- Page 380:
Formulation and Approval of Credent
- Page 384:
Formulation and Approval of Credent
- Page 388:
Formulation and Approval of Credent
- Page 392:
Formulation and Approval of Credent
- Page 396:
Formulation and Approval of Credent
- Page 400:
Formulation and Approval of Credent
- Page 404:
Formulation and Approval of Credent
- Page 408:
Formulation and Approval of Credent
- Page 412:
Formulation and Approval of Credent
- Page 416:
Formulation and Approval of Credent
- Page 420:
ReferencesFormulation and Approval
- Page 424:
Formulation and Approval of Credent
- Page 428:
C H A P T E R 7Reimbursementfor Exp
- Page 432:
Reimbursement for Expanded Professi
- Page 436:
Reimbursement for Expanded Professi
- Page 440:
Reimbursement for Expanded Professi
- Page 444:
Reimbursement for Expanded Professi
- Page 448:
Reimbursement for Expanded Professi
- Page 452:
Reimbursement for Expanded Professi
- Page 456:
Reimbursement for Expanded Professi
- Page 460:
Reimbursement for Expanded Professi
- Page 464:
Reimbursement for Expanded Professi
- Page 468:
Reimbursement for Expanded Professi
- Page 472:
Reimbursement for Expanded Professi
- Page 476:
Reimbursement for Expanded Professi
- Page 480:
INFLATIONARY PAYMENT SYSTEMSReimbur
- Page 484:
Reimbursement for Expanded Professi
- Page 488:
Reimbursement for Expanded Professi
- Page 492:
Reimbursement for Expanded Professi
- Page 496:
ReferencesReimbursement for Expande
- Page 500:
Reimbursement for Expanded Professi
- Page 504:
Reimbursement for Expanded Professi
- Page 508:
C H A P T E R 8Marketing the Role:F
- Page 512:
Marketing the Role: Formulating, Ar
- Page 516:
Marketing the Role: Formulating, Ar
- Page 520:
Marketing the Role: Formulating, Ar
- Page 524:
Marketing the Role: Formulating, Ar
- Page 528:
Marketing the Role: Formulating, Ar
- Page 532:
Marketing the Role: Formulating, Ar
- Page 536:
Marketing the Role: Formulating, Ar
- Page 540:
Marketing the Role: Formulating, Ar
- Page 544:
Marketing the Role: Formulating, Ar
- Page 548:
Marketing the Role: Formulating, Ar
- Page 552:
Marketing the Role: Formulating, Ar
- Page 556:
Marketing the Role: Formulating, Ar
- Page 560:
C H A P T E R 9Advanced PracticeNur
- Page 564:
Advanced Practice Nursing: Inquiry
- Page 568:
Advanced Practice Nursing: Inquiry
- Page 572:
Advanced Practice Nursing: Inquiry
- Page 576:
Advanced Practice Nursing: Inquiry
- Page 580:
Advanced Practice Nursing: Inquiry
- Page 584:
Advanced Practice Nursing: Inquiry
- Page 588:
Advanced Practice Nursing: Inquiry
- Page 592:
Advanced Practice Nursing: Inquiry
- Page 596:
Advanced Practice Nursing: Inquiry
- Page 600:
Advanced Practice Nursing: Inquiry
- Page 604:
Advanced Practice Nursing: Inquiry
- Page 608:
Advanced Practice Nursing: Inquiry
- Page 612:
Advanced Practice Nursing: Inquiry
- Page 616:
Advanced Practice Nursing: Inquiry
- Page 620:
Advanced Practice Nursing: Inquiry
- Page 624:
C H A P T E R 1 0Publishingin Nursi
- Page 628:
Publishing in Nursing Journals 281P
- Page 632:
Publishing in Nursing Journals 283T
- Page 636:
Publishing in Nursing Journals 285a
- Page 640:
Publishing in Nursing Journals 287b
- Page 644:
Publishing in Nursing Journals 289A
- Page 648:
Publishing in Nursing Journals 291S
- Page 652:
C H A P T E R 1 1Legal and EthicalA
- Page 656:
Legal and Ethical Aspects of Advanc
- Page 660:
Legal and Ethical Aspects of Advanc
- Page 664:
Legal and Ethical Aspects of Advanc
- Page 668:
Legal and Ethical Aspects of Advanc
- Page 672:
Legal and Ethical Aspects of Advanc
- Page 676:
Legal and Ethical Aspects of Advanc
- Page 680:
AUTONOMY VS. BENEFICENCELegal and E
- Page 684:
Legal and Ethical Aspects of Advanc
- Page 688:
Legal and Ethical Aspects of Advanc
- Page 692:
Legal and Ethical Aspects of Advanc
- Page 696:
Legal and Ethical Aspects of Advanc
- Page 700:
Legal and Ethical Aspects of Advanc
- Page 704:
Legal and Ethical Aspects of Advanc
- Page 708:
Legal and Ethical Aspects of Advanc
- Page 712:
Legal and Ethical Aspects of Advanc
- Page 716:
Legal and Ethical Aspects of Advanc
- Page 720:
C H A P T E R 1 2Global Healthand I
- Page 724:
Global Health and International Opp
- Page 728:
Global Health and International Opp
- Page 732:
Global Health and International Opp
- Page 736:
Global Health and International Opp
- Page 740:
Global Health and International Opp
- Page 744:
Global Health and International Opp
- Page 748:
■ Teaching-coaching function■ P
- Page 752:
Global Health and International Opp
- Page 756:
Global Health and International Opp
- Page 760:
Global Health and International Opp
- Page 764:
Global Health and International Opp
- Page 768:
C H A P T E R 1 3Advanced PracticeN
- Page 772:
Advanced Practice Nursing and Healt
- Page 776:
Advanced Practice Nursing and Healt
- Page 780:
Advanced Practice Nursing and Healt
- Page 784:
Advanced Practice Nursing and Healt
- Page 788:
Advanced Practice Nursing and Healt
- Page 792:
Advanced Practice Nursing and Healt
- Page 796:
Advanced Practice Nursing and Healt
- Page 800:
Advanced Practice Nursing and Healt
- Page 804:
Advanced Practice Nursing and Healt
- Page 808:
Advanced Practice Nursing and Healt
- Page 812:
Advanced Practice Nursing and Healt
- Page 816:
ReferencesAdvanced Practice Nursing
- Page 820:
Advanced Practice Nursing and Healt
- Page 824:
C H A P T E R 1 4The Advanced Pract
- Page 828:
The Advanced Practice Registered Nu
- Page 832:
The Advanced Practice Registered Nu
- Page 836:
The Advanced Practice Registered Nu
- Page 840:
The Advanced Practice Registered Nu
- Page 844:
The Advanced Practice Registered Nu
- Page 848:
The Advanced Practice Registered Nu
- Page 852:
The Advanced Practice Registered Nu
- Page 856:
The Advanced Practice Registered Nu
- Page 860:
The Advanced Practice Registered Nu
- Page 864:
The Advanced Practice Registered Nu
- Page 868:
C H A P T E R 1 5Clinical Microsyst
- Page 872:
Clinical Microsystem Thinking and R
- Page 876:
Clinical Microsystem Thinking and R
- Page 880:
Clinical Microsystem Thinking and R
- Page 884:
Clinical Microsystem Thinking and R
- Page 888:
Clinical Microsystem Thinking and R
- Page 892:
Clinical Microsystem Thinking and R
- Page 896:
Clinical Microsystem Thinking and R
- Page 900:
C H A P T E R 1 6The Future of APRN
- Page 904:
The Future of APRN Practice and the
- Page 908:
The Future of APRN Practice and the
- Page 912:
The Future of APRN Practice and the
- Page 916:
IndexNote: Page numbers followed by
- Page 920:
Index 427doctoral, new paths to, 55
- Page 924:
Index 429APRNs’ service in, 335as
- Page 928:
Index 431ethnic makeup, 35families,